Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X:
“How does SG perform in Active BC brain metastases?
33 patients with HER2-negative MBC and CNS metastases.
CNS ORR = 4/30 (13%)
Median CNS-progression-free survival=2.9 months (95%CI:2.0–4.3)
Huge area of unmet need.”
Authors: Thomas Grinda, Sarah Sammons et al.
